ASX - By Stock
|
SIG |
Re:
General Discussion
|
|
vfpa5000000
|
79 |
44K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
79
|
44K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Resignation of Chief Financial Officer
|
|
vfpa5000000
|
72 |
18K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
72
|
18K
|
5
|
|
ASX - By Stock
|
AD8 |
Re:
$23 Valuation
|
|
vfpa5000000
|
1 |
468 |
1 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
1
|
468
|
1
|
|
ASX - By Stock
|
AD8 |
$23 Valuation
|
|
vfpa5000000
|
1 |
468 |
1 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
1
|
468
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
vfpa5000000
|
148 |
45K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
148
|
45K
|
5
|
|
ASX - By Stock
|
TPW |
Re:
Ann: On-market Share Buy Back Program
|
|
vfpa5000000
|
5 |
1.0K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
5
|
1.0K
|
0
|
|
ASX - By Stock
|
TPW |
Re:
Ann: On-market Share Buy Back Program
|
|
vfpa5000000
|
5 |
1.0K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
5
|
1.0K
|
0
|
|
ASX - By Stock
|
LLC |
Re:
Ann: Lendlease Strategy Update
|
|
vfpa5000000
|
25 |
7.6K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
25
|
7.6K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Submits NDA for New Prostate Cancer Imaging Agent
|
|
vfpa5000000
|
24 |
8.5K |
3 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
24
|
8.5K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
vfpa5000000
|
475 |
151K |
7 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
475
|
151K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
vfpa5000000
|
937 |
428K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
937
|
428K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
vfpa5000000
|
937 |
428K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
937
|
428K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
vfpa5000000
|
40 |
11K |
0 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
vfpa5000000
|
40 |
11K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
vfpa5000000
|
40 |
11K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
vfpa5000000
|
40 |
11K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
vfpa5000000
|
40 |
11K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
vfpa5000000
|
61 |
24K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
61
|
24K
|
6
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
vfpa5000000
|
137 |
62K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
137
|
62K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
vfpa5000000
|
137 |
62K |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
137
|
62K
|
3
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
vfpa5000000
|
137 |
62K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
137
|
62K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
vfpa5000000
|
137 |
62K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
137
|
62K
|
3
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
vfpa5000000
|
137 |
62K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
137
|
62K
|
6
|
|
ASX - By Stock
|
AX1 |
Re:
Ann: Trading Update
|
|
vfpa5000000
|
62 |
28K |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
62
|
28K
|
0
|
|
ASX - By Stock
|
AX1 |
Re:
Ann: Trading Update
|
|
vfpa5000000
|
62 |
28K |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
62
|
28K
|
1
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
1
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
1
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
2 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
2
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
1
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
2 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
2
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
0
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
4 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
4
|
|
ASX - By Stock
|
MP1 |
Re:
Ann: 1Q FY24 Investor Presentation
|
|
vfpa5000000
|
40 |
20K |
6 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
40
|
20K
|
6
|
|
ASX - By Stock
|
PDN |
Re:
A nice short opportunity
|
|
vfpa5000000
|
214 |
96K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
214
|
96K
|
0
|
|
ASX - By Stock
|
PDN |
Re:
A nice short opportunity
|
|
vfpa5000000
|
214 |
96K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
214
|
96K
|
0
|
|
ASX - By Stock
|
PDN |
Re:
A nice short opportunity
|
|
vfpa5000000
|
214 |
96K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
214
|
96K
|
1
|
|
ASX - By Stock
|
PDN |
Re:
A nice short opportunity
|
|
vfpa5000000
|
214 |
96K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
214
|
96K
|
1
|
|
ASX - By Stock
|
PDN |
Re:
A nice short opportunity
|
|
vfpa5000000
|
214 |
96K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
214
|
96K
|
1
|
|
ASX - By Stock
|
PDN |
Re:
THE SQUEEZE IS ON
|
|
vfpa5000000
|
2.4K |
1.1M |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
PDN |
Re:
THE SQUEEZE IS ON
|
|
vfpa5000000
|
2.4K |
1.1M |
0 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
PDN |
Re:
THE SQUEEZE IS ON
|
|
vfpa5000000
|
2.4K |
1.1M |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
0 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
25
|
12K
|
0
|
|
ASX - By Stock
|
HLI |
Re:
$100m On-Market share buy back from September 2023
|
|
vfpa5000000
|
18 |
5.4K |
0 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
18
|
5.4K
|
0
|
|
ASX - By Stock
|
HLI |
Re:
$100m On-Market share buy back from September 2023
|
|
vfpa5000000
|
18 |
5.4K |
1 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
18
|
5.4K
|
1
|
|
ASX - By Stock
|
HLI |
Re:
Proportion of profitable house sales increasing
|
|
vfpa5000000
|
2 |
583 |
1 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
2
|
583
|
1
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
25
|
12K
|
3
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
3 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
25
|
12K
|
3
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
2 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
25
|
12K
|
2
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
1 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
25
|
12K
|
1
|
|
ASX - By Stock
|
APX |
Re:
APX prime for takeover with $108m valuation and 0.25x revenue multiple
|
|
vfpa5000000
|
25 |
12K |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
25
|
12K
|
8
|
|